Duchenne muscular dystrophy patients are focus of GLP-1 therapy for obesity study
August 26, 2026
August 26, 2026
NASHVILLE, Tennessee, Aug. 26 -- Vanderbilt University Medical Center posted the following news release:
* * *
Duchenne muscular dystrophy patients are focus of GLP-1 therapy for obesity study
*
About half of patients with Duchenne muscular dystrophy (DMD), a life-limiting disease with limited therapeutic options and no cure, have elevated body mass indexes (BMI) in the overweight or obesity range due to a combination of factors including limit . . .
* * *
Duchenne muscular dystrophy patients are focus of GLP-1 therapy for obesity study
*
About half of patients with Duchenne muscular dystrophy (DMD), a life-limiting disease with limited therapeutic options and no cure, have elevated body mass indexes (BMI) in the overweight or obesity range due to a combination of factors including limit . . .